+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis - By Treatment and Sublingual Immunotherapy, and Geography

  • ID: 5180786
  • Report
  • September 2020
  • Region: North America
  • 95 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK Abello A/S
  • Anergis
  • Circassia
  • MORE
The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3 % during the forecast period.

This can be attributed to the increasing developments in the healthcare sector. The rising initiatives by various research institutes and organizations for improving medical facilities and services are further leading to the market growth.

Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. According to the American Academy of Allergy, Asthma, and Immunology (AAAAI), 7.8% of people aged 18 years and above in the US have allergic rhinitis. Further, 30% of the global population is affected by hay fever annually. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs. Thus, growing prevalence of different allergies and increasing drug development activities boost the North America allergy immunotherapies market growth. The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.

The COVID-19 pandemic has harmed the North America allergy immunotherapies market size, with small and medium-scale companies struggling to sustain their businesses in the near future. Industry leaders are now focusing on creating new business practices to deal with such crises.

The North America allergy immunotherapies market, based on Treatment, is segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). In 2019, the SCIT segment held a larger share of the market. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. The North America allergy immunotherapies market, based on allergy type, is segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment held the greatest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during forecast period.

The North America allergy immunotherapies market, based on distribution channel, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, and market for the same segment is expected to grow at the fastest CAGR during the forecast period.

A few of the major primary and secondary sources associated with this report on the North America allergy immunotherapies market are the American Academy of Allergy, Asthma & Immunology, Celsion Corporation, the US Food and Drug Administration (FDA), and World Allergy Organization (WAO).
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK Abello A/S
  • Anergis
  • Circassia
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Allergy Immunotherapies Market - By Treatment
1.3.2 North America Allergy Immunotherapies Market - By Allergy Type
1.3.3 North America Allergy Immunotherapies Market - By Distribution Channel
1.3.4 North America Allergy Immunotherapies Market - By Geography

2. North America Allergy Immunotherapies Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Allergy Immunotherapies Market - Market Landscape
4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion

5. North America Allergy immunotherapies Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis

6. Allergy Immunotherapies Market - North America Analysis
6.1.1 North America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)

7. North America Allergy Immunotherapies Market Analysis- by Treatment
7.1 Overview
7.2 North America Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

8. North America Allergy Immunotherapies Market Analysis- by Allergy Type
8.1 Overview
8.2 North America Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

9. North America Allergy Immunotherapies Market Analysis- by Distribution Channel
9.1 Overview
9.2 North America Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 North America Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

10. Allergy Immunotherapies - Geographic Analysis
10.1.1 Overview
10.1.2 orth America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Allergy Immunotherapies Market

12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson and Johnson Services, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

13. Appendix
13.1 Glossary of Terms
Note: Product cover images may vary from those shown
  • Johnson and Johnson Services, Inc.
  • ALK Abello A/S
  • Aimmune Therapeutics
  • Anergis
  • Circassia
Note: Product cover images may vary from those shown
Adroll
adroll